1678 related articles for article (PubMed ID: 10690586)
21. [Inflammatory bowel disease and colorectal cancer].
Hagymási K; Tulassay Z
Orv Hetil; 2006 Oct; 147(41):1977-82. PubMed ID: 17120688
[TBL] [Abstract][Full Text] [Related]
22. [The malignant side of chronic inflammatory bowel disease].
West RL; van de Vrie W; Schouten WR; van Dekken H; Kuipers EJ
Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2521-4. PubMed ID: 12532661
[TBL] [Abstract][Full Text] [Related]
23. Review article: the effect of aminosalicylates and immunomodulation on cancer risk in inflammatory bowel disease.
Stange EF
Aliment Pharmacol Ther; 2006 Oct; 24 Suppl 3():64-7. PubMed ID: 16961748
[TBL] [Abstract][Full Text] [Related]
24. Endoscopic screening for dysplasia and mucosal aneuploidy in adolescents and young adults with childhood onset colitis.
Markowitz J; McKinley M; Kahn E; Stiel L; Rosa J; Grancher K; Daum F
Am J Gastroenterol; 1997 Nov; 92(11):2001-6. PubMed ID: 9362180
[TBL] [Abstract][Full Text] [Related]
25. Colon cancer in inflammatory bowel disease: recent trends, questions and answers.
Viennot S; Deleporte A; Moussata D; Nancey S; Flourié B; Reimund JM
Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S190-201. PubMed ID: 20117342
[TBL] [Abstract][Full Text] [Related]
26. A high degree of aneuploidy, loss of p53 gene, and low soluble p53 protein serum levels are detected in ulcerative colitis patients.
Rosman-Urbach M; Niv Y; Birk Y; Smirnoff P; Zusman I; Morgenstern S; Schwartz B
Dis Colon Rectum; 2004 Mar; 47(3):304-13. PubMed ID: 14991492
[TBL] [Abstract][Full Text] [Related]
27. Malignant transformation in inflammatory bowel disease - surveillance guide.
Stallmach A; Bielecki C; Schmidt C
Dig Dis; 2009; 27(4):584-90. PubMed ID: 19897979
[TBL] [Abstract][Full Text] [Related]
28. Associated neoplastic disease in inflammatory bowel disease.
Cendan JC; Behrns KE
Surg Clin North Am; 2007 Jun; 87(3):659-72. PubMed ID: 17560418
[TBL] [Abstract][Full Text] [Related]
29. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?
Rubin DT; Rothe JA; Hetzel JT; Cohen RD; Hanauer SB
Gastrointest Endosc; 2007 Jun; 65(7):998-1004. PubMed ID: 17451704
[TBL] [Abstract][Full Text] [Related]
30. Dysplasia and cancer in ulcerative colitis: a soluble problem?
Riddell RH
Scand J Gastroenterol Suppl; 1984; 104():137-49. PubMed ID: 6597546
[TBL] [Abstract][Full Text] [Related]
31. Aberrant crypt foci as precursors of the dysplasia-carcinoma sequence in patients with ulcerative colitis.
Kukitsu T; Takayama T; Miyanishi K; Nobuoka A; Katsuki S; Sato Y; Takimoto R; Matsunaga T; Kato J; Sonoda T; Sakamaki S; Niitsu Y
Clin Cancer Res; 2008 Jan; 14(1):48-54. PubMed ID: 18172251
[TBL] [Abstract][Full Text] [Related]
32. Dysplasia in inflammatory bowel disease.
Greenson JK
Semin Diagn Pathol; 2002 Feb; 19(1):31-7. PubMed ID: 11936264
[TBL] [Abstract][Full Text] [Related]
33. [Tracing colorectal carcinoma in patients with inflammatory bowel disease].
de Jong DJ; Nagengast FM
Ned Tijdschr Geneeskd; 2007 Dec; 151(50):2758-60. PubMed ID: 18232192
[TBL] [Abstract][Full Text] [Related]
34. Pericholangitis and sclerosing cholangitis are risk factors for dysplasia and cancer in ulcerative colitis.
D'Haens GR; Lashner BA; Hanauer SB
Am J Gastroenterol; 1993 Aug; 88(8):1174-8. PubMed ID: 8338083
[TBL] [Abstract][Full Text] [Related]
35. Crohn's colitis: the incidence of dysplasia and adenocarcinoma in surgical patients.
Maykel JA; Hagerman G; Mellgren AF; Li SY; Alavi K; Baxter NN; Madoff RD
Dis Colon Rectum; 2006 Jul; 49(7):950-7. PubMed ID: 16729218
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical expression of P53 and oncogenes in ulcerative colitis-associated colorectal carcinoma.
Brüwer M; Schmid KW; Senninger N; Schürmann G
World J Surg; 2002 Mar; 26(3):390-6. PubMed ID: 11865380
[TBL] [Abstract][Full Text] [Related]
37. Ursodeoxycholic acid treatment in IBD-patients with colorectal dysplasia and/or DNA-aneuploidy: a prospective, double-blind, randomized controlled pilot study.
Sjöqvist U; Tribukait B; Ost A; Einarsson C; Oxelmark L; Löfberg R
Anticancer Res; 2004; 24(5B):3121-7. PubMed ID: 15510599
[TBL] [Abstract][Full Text] [Related]
38. Noncolorectal malignancies in inflammatory bowel disease: more than meets the eye.
Beaugerie L; Sokol H; Seksik P
Dig Dis; 2009; 27(3):375-81. PubMed ID: 19786768
[TBL] [Abstract][Full Text] [Related]
39. Cancer in inflammatory bowel disease.
Greenstein AJ
Mt Sinai J Med; 2000 May; 67(3):227-40. PubMed ID: 10828908
[TBL] [Abstract][Full Text] [Related]
40. Surveillance for dysplasia in patients with inflammatory bowel disease: a national survey of colonoscopic practice in New Zealand.
Gearry RB; Wakeman CJ; Barclay ML; Chapman BA; Collett JA; Burt MJ; Frizelle FA
Dis Colon Rectum; 2004 Mar; 47(3):314-22. PubMed ID: 14991493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
